Susquehanna Fundamental Investments, LLC Anavex Life Sciences Corp. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$9.74 - $17.69 $166,748 - $302,852	-17,120 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$16.82 - $25.75 $229,307 - $351,049	-13,633 Reduced 44.33%	17,120 $307,000
Q1 2021 May 17, 2021	BUY	$5.17 - $16.13 $88,510 - $276,145	17,120 Added 125.58%	30,753 $460,000
Q4 2020 Feb 16, 2021	SELL	$4.01 - $7.58 $60,551 - $114,458	-15,100 Reduced 52.55%	13,633 $74,000
Q3 2020 Nov 16, 2020	BUY	$3.8 - $5.0 $109,185 - $143,665	28,733 New	28,733 $131,000

152

26.5M

674K

811K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $436M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.